Table of Content

1 INTRODUCTION
1.1 Study Assumptions & Market Definition
1.2 Scope Of The Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in the Volume of Surgeries and Sports-related Injuries
4.2.2 Rising Awareness about the Medical Implications of Adhesions
4.3 Market Restraints
4.3.1 High Cost of Surgical Procedures Coupled with Side Effects Associated with Adhesion Barriers
4.3.2 Stringent Regulations Resulting in Limited Technological Innovations
4.4 Industry Attractiveness - Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION (Market Size by Value – USD Million)
5.1 By Product
5.1.1 Synthetic Adhesion Barriers
5.1.1.1 Hyaluronic Acid
5.1.1.2 Regenerated Cellulose
5.1.1.3 Polyethylene Glycol
5.1.1.4 Other Synthetic Adhesion Barriers
5.1.2 Natural Adhesion Barriers
5.1.2.1 Collagen
5.1.2.2 Fibrin
5.2 By Formulation
5.2.1 Film
5.2.2 Liquid
5.2.3 Gel
5.3 By Application
5.3.1 General/Abdominal Surgeries
5.3.2 Gynecological Surgeries
5.3.3 Cardiovascular Surgeries
5.3.4 Orthopedic Surgeries
5.3.5 Neurological Surgeries
5.3.6 Other Applications
5.4 By Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Anika Therapeutics
6.1.2 Baxter International
6.1.3 Leader Biomedical
6.1.4 Betatech Medical
6.1.5 FzioMed
6.1.6 BIOSCOMPASS, INC.
6.1.7 Integra LifeSciences Holdings Corporation
6.1.8 Johnson & Johnson
6.1.9 GUNZE LIMITED
6.1.10 Wuhan Sitaili Medical Apparatus Development Co.
6.1.11 TAICEND TECHNOLOGY CO., LTD
6.1.12 MAST Biosurgery


7 MARKET OPPORTUNITIES AND FUTURE TRENDS